Clinical categorization algorithm (CLICAL) and machine learning approach (SRF-CLICAL) to predict clinical benefit to immunotherapy in metastatic melanoma …
G Madonna, GV Masucci, M Capone, D Mallardo… - Cancers, 2021 - mdpi.com
Simple Summary Immune checkpoint inhibitors have improved the prognosis for patients
with advanced melanoma. Despite the recent success of immunotherapy, many patients still …
with advanced melanoma. Despite the recent success of immunotherapy, many patients still …
[PDF][PDF] Clinical Categorization Algorithm (CLICAL) and Machine Learning Approach (SRF-CLICAL) to Predict Clinical Benefit to Immunotherapy in Metastatic …
G Madonna, GV Masucci, M Capone, D Mallardo… - 2021 - academia.edu
The real-life application of immune checkpoint inhibitors (ICIs) may yield different outcomes
compared to the benefit presented in clinical trials. For this reason, there is a need to define …
compared to the benefit presented in clinical trials. For this reason, there is a need to define …